Quanta Therapeutics, Inc. — Form D/A

Quanta Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2026-06-24. The offering totals $89.1M, of which $76.2M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-06-24
• Form: D/A
• Accession: 0001891891-26-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $89.1M
• Amount sold: $76.2M
• Remaining: $12.9M
• Investors: 17
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-482575

Issuer

• Name: Quanta Therapeutics, Inc.
• CIK: 0001891891
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: TWO TOWER PLACE, FLOOR 17, SOUTH SAN FRANCISCO, CA, 94080
• Phone: (970) 742-4190

Officers, directors & promoters (17)

Other filings by this issuer (3)

More

• CIK 1891891 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search